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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
This review aims to look at the benefits and harms of interventions for improving health literacy in patients with CKD.
B A C K G R O U N D
Description of the condition
Chronic kidney disease (CKD) is a worldwide health problem,
with an estimated 10% to 13% of the world’s population being
affected (Couser 2011; Szczech 2009). CKD is classified into 5
stages; stage 1 and 2 are considered mild, stage 3 and 4 are consid-
eredmoderate and stage 5 is referred to as end stage kidney disease
(ESKD). Stages 1 to 4 CKD have been independently associated
with diabetes, hypertension, cardiovascular disease, some cancers,
increased hospitalisations and acute kidney injury (Hsu 2008).
Specifically there is an increased cardiovascular related mortality
even in very early disease (Hallan 2006). The aims of stage 1 to 4
CKD management include decreasing progression to ESKD and
the risk of cardiovascular complications through management of
kidney function and common factors of CKD progression such as
hypertension and diabetes. Effective treatment methods include
but are not limited to decreasing hypertension, decreasing pro-
teinuria, increasing glycaemic control, encouraging weight loss
and healthy-living behaviours, smoking cessation and treatment
of other cardiovascular risk factors such as dyslipidaemia (James
2010).
Only a minority of stage 1 to 4 CKD patients go on to develop
kidney failure or ESKD.This is partly because of the increased risk
of mortality in earlier stages of kidney disease from other related
comorbidities (Go 2004). ESKD can require renal replacement
therapy (RRT) in the form of dialysis or kidney transplant, or can
1Interventions for improving health literacy in people with chronic kidney disease (Protocol)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
be managed in a more conservative way usually in older patient
with multiple co-morbidities. ESKD is associated with extremely
high mortality, morbidity and a substantially low quality of life
(Foley 1998). More than 2 million people worldwide are being
kept alive byRRThowever this is thought to only account for 10%
of those who need it (Eggers 2011). The high financial and social
cost of ESKDtoboth individuals and society place it as a significant
health priority in the field of non-communicable diseases and it
is considered a death sentence in many developing countries (De
Vecchi 1999).
Description of the intervention
The long term management of both CKD requires a high level
of patient involvement both in decision making and implemen-
tation of care. For patients to be effective at health decision mak-
ing and self-management they must possess the ability to under-
stand and utilise health information, a skill which is referred to as
‘health literacy’ (Nielsen-Bohlman 2004). The concept of health
literacy can be approached in two ways, health literacy can be seen
as a risk factor or as an asset, however these two ideas are not
mutually exclusive. Health literacy as a risk factor - the idea that
low health literacy is a risk for poorer health outcomes - has been
widely investigated. Low health literacy has been associated with
an increase in mortality and poorer overall health status (Berkman
2011). Those with lower general literacy are more likely to have
a lower level of knowledge and comprehension regarding health
related issues, have fewer immunisations and health screenings,
have more hospitalisations and be admitted to emergency more
frequently than those on the other end of the spectrum (Berkman
2011; Dewalt 2004). Some health literacy interventions aim to
mitigate the negative effects of low health literacy, improve pa-
tients’ literacy or make it easier for those with low health literacy
to understand and access health information. Health literacy can
also be viewed as an asset, a skill that can be built through pa-
tient education, although this concept requires further solidifica-
tion. Within this framework health literacy is seen as an outcome
of health education and communication rather than a factor that
may lead to poorer health outcomes. Health literacy interventions
that are treating health literacy as an asset have a wider variety of
aims including developing self-management abilities, improving
patients’ ability negotiate or navigate within the health system,
improving patients’ ability to understand and implement health-
care information. These interventions are not necessarily aimed at
those with low health literacy and could in theory help any patient.
A more detailed appraisal of these two similar but distinct con-
ceptualisations of health literacy can be found in the paper “The
evolving concept of health literacy” (Nutbeam 2008). Both health
literacy, the risk factor, and health literacy, the asset, impact on
the ability for a patient to competently manage a health problem,
especially in the context of chronic disease such as CKD which
has an extremely high level of patient involvement in care. This
study treats all interventions that fall under either category as a
‘health literacy intervention’ as the separation of the two types of
intervention seems counter intuitive in this setting.
The evidence about the effectiveness of specific health literacy in-
terventions is still emerging. There is no standardised interven-
tion to date, and there may never be, however some common de-
sign features have been found to improve health literacy (Sheridan
2011).
• Presenting written information in a different way (e.g.
giving essential information first)
• Presenting numerical information in a different way (e.g.
highest number is always better)
• Use of icons and symbols and graphs
• Presenting information pitched at a lower literacy level (e.g.
that of primary school comprehension)
• Use of video tutorials
• Literacy training for physicians
• Implementing self-management plans.
How the intervention might work
There is evidence that health literacy interventions can reduce
emergency department visits, hospitalisations and disease severity
in other chronic diseases. Specifically within CKD low health lit-
eracy has been found to be associated with a higher risk of death
(Cavanaugh 2010) and also a lower likelihood of being referred
for transplant (Grubbs 2009). Low health literacy was found to
be common among CKD patients in a systematic review in 2013,
however the studies in this review predominately looked at patients
with ESKD (Fraser 2013). Since then one study has investigated
the prevalence of low health literacy specifically in those with stage
1 to 4 CKD and found that low health literacy is also common
in this sub population of patients (Devraj 2015). This study also
found a small but significant positive relationship between kidney
function (estimated glomerular filtration rate (eGFR)) and health
literacy. Due to the link between low health literacy and poorer
health outcomes and the indication that it is prevalent in CKD
and ESKD patients it follows that improving the health literacy
of these patients could have a positive effect on their health out-
comes.
Health literacy interventions are not just about reducing the risk
for those with low health literacy, but also about improving the
health management of any individual. This is most important in
diseases which require a high level of patient involvement, such as
CKD. The management of CKD is complex and requires patients
to understand the impact many different things including but not
limited to blood pressure, weight, cholesterol, fluid intake, diet,
exercise, medications both adherence and interactions as well as
navigate the health system and interact with many different health
care providers. Health literacy interventions aimed at improving
an individual’s self-management ability could be incredibly useful
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in the setting of stage 1 to 4 CKD or ESKD and this study will
investigate both populations.
Why it is important to do this review
Health literacy and how to improve it has been identified as a
central research priority both by Kidney Health Australia and The
National Institute of Diabetes and Digestive and Kidney Diseases
in Canada (Manns 2014; Tong 2015). It is now well accepted
that a high proportion of patients with CKD do have low health
literacy as measured by an array of health literacy measurement
tools (Dageforde 2013; Kutner 2006). Those at higher risk for
developing CKD may also be at high risk for having low health
literacy as both low health literacy and CKD are disproportion-
ally apparent in those who have low educational status, are from
low socioeconomic backgrounds, are from minority groups and
are of an older age (Dageforde 2013; Kutner 2006). Research into
health literacy interventions thus far has been broad focusing on
all chronic disease (Sheridan 2011) however patients with CKD
have specific complications and outcomes that should be analysed
separately. One example of this is the decrease in cognitive ability
seen in CKD patients. CKD is an independent risk factor for the
development of cognitive decline (Etgen 2012) and is thought to
be related to cognitive impairment both directly through inflam-
mation, toxins, and dialysis and indirectly through related com-
plications such as hypertension and diabetes (Bugnicourt 2013).
A review of health literacy interventions specifically targeted to pa-
tients with CKD will provide more focused information, as what
works in one chronic disease may not work in another. Van Scoyoc
2010 completed a similar review analysing health literacy inter-
ventions in patients with diabetes. They highlighted the aspects of
the interventions that had an impact on health outcomes, and the
ones that had no effect, delivering information for future develop-
ment of health literacy interventions in this population. This re-
view expects similar results and hopes to forward the development
of tools to improve healthcare for those with low health literacy in
the CKD population.
O B J E C T I V E S
This review aims to look at the benefits and harms of interventions
for improving health literacy in patients with CKD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs), quasi-RCTs (RCTs in
which allocation to treatment where allocation to treatment was
obtained by alternation, use of alternate medical records, date of
birth or other predictable methods), cluster RCTs, cohort studies
and non-randomised controlled studies looking at interventions
for improving health literacy in patients with CKD.
Types of participants
Inclusion criteria
Patients with CKD defined by abnormalities of kidney structure
or function, present for > 3 months, with implications for health
(KDIGO 2012), with one or more markers of kidney damage.
• Albuminuria (albumin excretion ratio (AER) Z30 mg/24 h;
albumin-creatinine ratio (ACR) Z30 mg/g (Z3 mg/mmol))
• Urine sediment abnormalities
• Electrolyte and other abnormalities due to tubular disorders
• Abnormalities detected by histology
• Structural abnormalities detected by imaging
• History of kidney transplantation
• Decreased GFR: GFR < 60 mL/min/1.73 m2 (GFR
categories G3a to G5)
Exclusion criteria
• Children (< 18 years) or those under guardianship, proxies
(carers).
• Studies with populations including people without CKD,
perhaps another chronic disease, will only be included if the data
for the CKD patients can be analysed separately.
Types of interventions
Any intervention that the authors report to be aimed at improving
health literacy. This may include interventions that aim to:
• Mitigate the effects of low health literacy
• Facilitate literacy skill building
• Improve knowledge about disease and treatment
• Improving self care
• Improving comprehension skills.
The types of comparisons will include the following.
• Health literacy intervention versus placebo
• Health literacy intervention versus other intervention not
aimed at improving health literacy
• Health literacy intervention versus another health literacy
intervention.
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Types of outcome measures
Primary outcomes
1. Progression of kidney disease (change in GFR, doubling of
serum creatinine, progression of CKD stage)
2. Health literacy (improvement on an accepted health literacy
measurement tool, knowledge, skills, self-management,
involvement with care)
Secondary outcomes
1. Change in quality of life on a recognised quality of life scale
either general (e.g. QoL, SF36) or disease appropriate (e.g.
KDQOL)
2. Mortality (including cause-specific deaths, cardiovascular
and kidney disease related death)
3. Hospitalisations including use of emergency care and
length of stay
4. Complications of CKD (hypertension, diabetic control,
metabolic bone disease, anaemia)
5. Adverse outcomes of health literacy intervention
(depression, decreased self efficacy)
Search methods for identification of studies
Electronic searches
We will search the Cochrane Kidney and Transplant Specialised
Register through contact with the Trials Search Co-ordinator us-
ing search terms relevant to this review. The Specialised Register
contains studies identified from the following sources.
1. Monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL)
2. Weekly searches of MEDLINE OVID SP
3. Handsearching of kidney-related journals and the
proceedings of major kidney conferences
4. Searching of the current year of EMBASE OVID SP
5. Weekly current awareness alerts for selected kidney journals
6. Searches of the International Clinical Trials Register
(ICTRP) Search Portal and ClinicalTrials.gov.
Studies contained in the SpecialisedRegister are identified through
search strategies for CENTRAL,MEDLINE, andEMBASE based
on the scope of Cochrane Kidney and Transplant. Details of these
strategies, as well as a list of handsearched journals, conference
proceedings and current awareness alerts, are available in the Spe-
cialised Register section of information about Cochrane Kidney
and Transplant.
See Appendix 1 for search terms used in strategies for this review.
Searching other resources
1. Reference lists of review articles, relevant studies and
clinical practice guidelines.
2. Letters seeking information about unpublished or
incomplete studies to investigators known to be involved in
previous studies.
Data collection and analysis
Selection of studies
The search strategy described will be used to obtain titles and
abstracts of studies that may be relevant to the review. The titles
and abstracts will be screened independently by two authors, who
will discard studies that are not applicable; however studies and
reviews that might include relevant data or information on studies
will be retained initially. Two authors will independently assess
retrieved abstracts and, if necessary the full text, of these studies to
determine which studies satisfy the inclusion criteria. Difference
between authors in the screening will be reconciled by discussion
and if needed inclusion of a third party.
Data extraction and management
Data extraction will be carried out independently by two authors
using standard data extraction forms. Studies reported in non-
English language journals will be translated before assessment.
Where more than one publication of one study exists, reports will
be grouped together and the publication with the most complete
data will be used in the analyses. Where relevant outcomes are
only published in earlier versions these data will be used. Any
discrepancy between published versions will be highlighted.
Assessment of risk of bias in included studies
The following items will be independently assessed by two authors
using the risk of bias assessment tool (Higgins 2011) (see Appendix
2).
• Was there adequate sequence generation (selection bias)?
• Was allocation adequately concealed (selection bias)?
• Was knowledge of the allocated interventions adequately
prevented during the study?
◦ Participants and personnel (performance bias)
◦ Outcome assessors (detection bias)
• Were incomplete outcome data adequately addressed
(attrition bias)?
• Are reports of the study free of suggestion of selective
outcome reporting (reporting bias)?
• Was the study apparently free of other problems that could
put it at a risk of bias?
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For non-randomised studies the ACROBAT-NRSI will be used
(Sterne 2014). Two authors will use this tool to independently
assess the risk of bias of each included study.
Measures of treatment effect
For dichotomous outcomes (e.g. death, number of patients pro-
gressing to ESKD) results will be expressed as risk ratio (RR) with
95% confidence intervals (CI). Where continuous scales of mea-
surement are used to assess the effects of treatment (health literacy
measurement, length of hospital stay), the mean difference (MD)
will be used, or the standardised mean difference (SMD) if differ-
ent scales have been used.
Unit of analysis issues
Cluster RCTs will be analysed in one of two ways.
1. Using a statistical analysis that properly accounts for the
cluster design. Some examples of these are based on a ‘multi level
model’, a ‘variance components analysis’ or may use ‘generalised
estimating equations’ (Higgins 2011)
2. Conduct the analysis treating the sample size as the number
of clusters and proceed as if the study were individually
randomised, treating the clusters as individuals.
When considering cross-over studies we will only use data from
the first period.
When considering studies with multiple treatment groups we will
try to combine all relevant experimental intervention groups of
the study into a single group and to combine all relevant control
intervention groups into a single group to enable single pair wise
comparison.
Dealing with missing data
Any further information required from the original author will be
requested by written correspondence (e.g. emailing corresponding
author) and any relevant information obtained in this manner
will be included in the review. Evaluation of important numerical
data such as screened, randomised patients as well as intention-
to-treat, as-treated and per-protocol population will be carefully
performed. Attrition rates, for example drop-outs, losses to follow-
up and withdrawals will be investigated. Issues of missing data
and imputation methods (for example, last-observation-carried-
forward) will be critically appraised (Higgins 2011).
Assessment of heterogeneity
Heterogeneity will be analysed using a Chi² test on N-1 degrees
of freedom, with an alpha of 0.05 used for statistical significance
and with the I² test (Higgins 2003). I² values of 25%, 50% and
75% correspond to low, medium and high levels of heterogeneity.
Assessment of reporting biases
If possible, funnel plots will be used to assess for the potential
existence of small study bias (Higgins 2011).
Data synthesis
Data will be pooled using the random-effects model but the fixed-
effect model will also be used to ensure robustness of the model
chosen and susceptibility to outliers.
Subgroup analysis and investigation of heterogeneity
Subgroup analysis will be used to explore possible sources of
heterogeneity (e.g. participants, interventions and study quality).
Heterogeneity among participants could be related to age, stage of
CKD, underlying concurrent disease states (e.g. diabetes), sever-
ity of health literacy proficiency, English proficiency. Specifically
we are interested in subgroup analysis of stage 1 to 4 CKD and
ESKD. Heterogeneity in treatments could be related to the way
the intervention is delivered (e.g. one-on-one, web based or in
groups) or the duration of the intervention.
If meta-analysis is not possible, adverse effects will be tabulated
and assessed with descriptive techniques, as they are likely to be
different for the various agents used. Where possible, the risk dif-
ference with 95% CI will be calculated for each adverse effect,
either compared to no treatment or to another agent.
Sensitivity analysis
We will perform sensitivity analyses in order to explore the influ-
ence of the following factors on effect size.
• Repeating the analysis excluding unpublished studies
• Repeating the analysis taking account of risk of bias, as
specified
• Repeating the analysis excluding any very long or large
studies to establish how much they dominate the results
• Repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), delivery medium (paper versus
electronic media versus other), stage of kidney disease (mild
versus moderate versus ESKD).
’Summary of findings’ tables
We will present the main results of the review in ’Summary of
findings’ tables. These tables present key information concerning
the quality of the evidence, the magnitude of the effects of the
interventions examined, and the sum of the available data for the
main outcomes (Schunemann 2011a). The ’Summary of findings’
tables also include an overall grading of the evidence related to
each of the main outcomes using the GRADE (Grades of Recom-
mendation, Assessment, Development and Evaluation) approach.
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The GRADE approach defines the quality of a body of evidence as
the extent to which one can be confident that an estimate of effect
or association is close to the true quantity of specific interest. The
quality of a body of evidence involves consideration of within-
trial risk of bias (methodological quality), directness of evidence,
heterogeneity, precision of effect estimates and risk of publication
bias (Schunemann 2011b).
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A P P E N D I C E S
Appendix 1. Electronic search strategies
Database Search terms
CENTRAL 1. MeSH descriptor: [Kidney Diseases] this term only
2. MeSH descriptor: [Renal Replacement Therapy] explode all trees
3. MeSH descriptor: [Renal Insufficiency] this term only
4. MeSH descriptor: [Renal Insufficiency, Chronic] this term only
5. hemodialysis or haemodialysis:ti,ab,kw (Word variations have been searched)
6. hemofiltration or haemofiltration:ti,ab,kw (Word variations have been searched)
7. hemodiafiltration or haemodiafiltration:ti,ab,kw (Word variations have been searched)
8. kidney disease* or renal disease* or kidney failure or renal failure:ti,ab,kw (Word variations have been searched)
9. ESRF or ESKF or ESRD or ESKD:ti,ab,kw (Word variations have been searched)
10. CKF or CKD or CRF or CRD:ti,ab,kw (Word variations have been searched)
11. CAPD or CCPD or APD:ti,ab,kw (Word variations have been searched)
12. predialysis or pre-dialysis:ti,ab,kw (Word variations have been searched)
13. {or #1-#12}
14. MeSH descriptor: [Health Literacy] this term only
15. MeSH descriptor: [Health Education] this term only
16. MeSH descriptor: [Consumer Health Information] this term only
17. MeSH descriptor: [Patient Education as Topic] this term only
18. MeSH descriptor: [Health Knowledge, Attitudes, Practice] this term only
19. MeSH descriptor: [Comprehension] this term only
20. MeSH descriptor: [Self Care] explode all trees
21. MeSH descriptor: [Educational Status] this term only
22. literacy or literate:ti,ab,kw (Word variations have been searched)
23. patient education:ti,ab,kw (Word variations have been searched)
24. self-management or self-car*:ti,ab,kw (Word variations have been searched)
25. {or #14-#24}
26. {and #13, #25}
MEDLINE 1. Health Literacy/
2. Health Education/
3. Consumer Health Information/
4. (literacy or literate).tw.
5. educational status/
6. Patient Education as Topic/
7. exp Self Care/
8. Health Knowledge, Attitudes, Practice/
9. Comprehension/
10. patient education.tw.
11. (self-management or self-car$).tw.
12. or/1-11
13. Kidney Diseases/
14. exp Renal Replacement Therapy/
15. Renal Insufficiency/
16. exp Renal Insufficiency, Chronic/
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(Continued)
17. dialysis.tw.
18. (hemodialysis or haemodialysis).tw.
19. (hemofiltration or haemofiltration).tw.
20. (hemodiafiltration or haemodiafiltration).tw.
21. (kidney disease* or renal disease* or kidney failure or renal failure).tw.
22. (ESRF or ESKF or ESRD or ESKD).tw.
23. (CKF or CKD or CRF or CRD).tw.
24. (CAPD or CCPD or APD).tw.
25. (predialysis or pre-dialysis).tw.
26. or/13-25
27. and/12,26
EMBASE 1. health education/
2. health literacy/
3. health promotion/
4. psychoeducation/
5. patient education/
6. nutrition education/
7. consumer health information/
8. exp comprehension/
9. (literacy or literate).tw.
10. (self-management or self-car$).tw.
11. patient education$.tw.
12. or/1-11
13. exp renal replacement therapy/
14. kidney disease/
15. chronic kidney disease/
16. kidney failure/
17. chronic kidney failure/
18. mild renal impairment/
19. stage 1 kidney disease/
20. moderate renal impairment/
21. severe renal impairment/
22. end stage renal disease/
23. renal replacement therapy-dependent renal disease/
24. kidney transplantation/
25. (hemodialysis or haemodialysis).tw.
26. (hemofiltration or haemofiltration).tw.
27. (hemodiafiltration or haemodiafiltration).tw.
28. dialysis.tw.
29. (CAPD or CCPD or APD).tw.
30. (kidney disease* or renal disease* or kidney failure or renal failure).tw.
31. (CKF or CKD or CRF or CRD).tw.
32. (ESRF or ESKF or ESRD or ESKD).tw.
33. (predialysis or pre-dialysis).tw.
34. ((kidney or renal) adj (transplant* or graft* or allograft*)).tw.
35. or/13-34
36. and/12,35
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Appendix 2. Risk of bias assessment tool
Potential source of bias Assessment criteria
Random sequence generation
Selection bias (biased allocation to interventions) due to inade-
quate generation of a randomised sequence
Low risk of bias: Random number table; computer random num-
ber generator; coin tossing; shuffling cards or envelopes; throwing
dice; drawing of lots; minimisation (minimisation may be imple-
mented without a random element, and this is considered to be
equivalent to being random)
High risk of bias: Sequence generated by odd or even date of birth;
date (or day) of admission; sequence generated by hospital or
clinic record number; allocation by judgement of the clinician; by
preference of the participant; based on the results of a laboratory
test or a series of tests; by availability of the intervention
Unclear: Insufficient information about the sequence generation
process to permit judgement
Allocation concealment
Selection bias (biased allocation to interventions) due to inade-
quate concealment of allocations prior to assignment
Low risk of bias: Randomisation method described that would not
allow investigator/participant to know or influence intervention
group before eligible participant entered in the study (e.g. central
allocation, including telephone, web-based, and pharmacy-con-
trolled, randomisation; sequentially numbered drug containers of
identical appearance; sequentially numbered, opaque, sealed en-
velopes)
High risk of bias:Using an open random allocation schedule (e.g. a
list of random numbers); assignment envelopes were used without
appropriate safeguards (e.g. if envelopes were unsealed or non-
opaque or not sequentially numbered); alternation or rotation;
date of birth; case record number; any other explicitly unconcealed
procedure
Unclear: Randomisation stated but no information on method
used is available
Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions
by participants and personnel during the study
Low risk of bias: No blinding or incomplete blinding, but the re-
view authors judge that the outcome is not likely to be influenced
by lack of blinding; blinding of participants and key study per-
sonnel ensured, and unlikely that the blinding could have been
broken
High risk of bias: No blinding or incomplete blinding, and the
outcome is likely to be influenced by lack of blinding; blinding
of key study participants and personnel attempted, but likely that
the blinding could have been broken, and the outcome is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
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(Continued)
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by
outcome assessors
Low risk of bias:Noblinding of outcome assessment, but the review
authors judge that the outcome measurement is not likely to be
influenced by lack of blinding; blinding of outcome assessment
ensured, and unlikely that the blinding could have been broken
High risk of bias: No blinding of outcome assessment, and the
outcome measurement is likely to be influenced by lack of blind-
ing; blinding of outcome assessment, but likely that the blinding
could have been broken, and the outcome measurement is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Incomplete outcome data
Attrition bias due to amount, nature or handling of incomplete
outcome data
Low risk of bias: No missing outcome data; reasons for missing
outcome data unlikely to be related to true outcome (for survival
data, censoring unlikely to be introducing bias); missing outcome
data balanced in numbers across intervention groups, with similar
reasons for missing data across groups; for dichotomous outcome
data, the proportion ofmissing outcomes comparedwith observed
event risk not enough to have a clinically relevant impact on the
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardised difference in
means) among missing outcomes not enough to have a clinically
relevant impact on observed effect size; missing data have been
imputed using appropriate methods
High risk of bias: Reason for missing outcome data likely to be
related to true outcome, with either imbalance in numbers or rea-
sons for missing data across intervention groups; for dichotomous
outcome data, the proportion ofmissing outcomes comparedwith
observed event risk enough to induce clinically relevant bias in
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes enough to induce clinically rel-
evant bias in observed effect size; ‘as-treated’ analysis done with
substantial departure of the intervention received from that as-
signed at randomisation; potentially inappropriate application of
simple imputation
Unclear: Insufficient information to permit judgement
Selective reporting
Reporting bias due to selective outcome reporting
Low risk of bias: The study protocol is available and all of the
study’s pre-specified (primary and secondary) outcomes that are of
interest in the review have been reported in the pre-specified way;
the study protocol is not available but it is clear that the published
reports include all expected outcomes, including those that were
pre-specified (convincing text of this nature may be uncommon)
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(Continued)
High risk of bias: Not all of the study’s pre-specified primary out-
comes have been reported; one or more primary outcomes is re-
ported using measurements, analysis methods or subsets of the
data (e.g. sub-scales) that were not pre-specified; one or more re-
ported primary outcomes were not pre-specified (unless clear jus-
tification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are
reported incompletely so that they cannot be entered in a meta-
analysis; the study report fails to include results for a key outcome
that would be expected to have been reported for such a study
Unclear: Insufficient information to permit judgement
Other bias
Bias due to problems not covered elsewhere in the table
Low risk of bias: The study appears to be free of other sources of
bias.
High risk of bias: Had a potential source of bias related to the spe-
cific study design used; stopped early due to some data-dependent
process (including a formal-stopping rule); had extreme baseline
imbalance; has been claimed to have been fraudulent; had some
other problem
Unclear: Insufficient information to assess whether an important
risk of bias exists; insufficient rationale or evidence that an iden-
tified problem will introduce bias
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